Is there already a Cosentyx biosimilar available?
Cosentyx (secukinumab) is a biologic used for conditions such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. As a result, many patients and clinicians look for “biosimilars to Cosentyx” as cheaper alternatives.
At the time this answer is based on the provided sources, I can’t confirm the existence or launch status of a biosimilar specifically for Cosentyx because no supporting information was provided here to verify which products are approved and sold in your market.
What’s the key difference between a “biosimilar” and an “interchangeable”?
Even when biosimilars exist, approval status can vary by country. A biosimilar may be authorized based on similarity to the reference product, while “interchangeable” status (where that designation exists) can affect pharmacy-level substitution rules. If you tell me your country (US, EU, UK, Canada, etc.), I can narrow this to the relevant regulator (FDA/EMA) approvals.
Where can I check the latest biosimilar status for Cosentyx?
DrugPatentWatch.com tracks patent and pipeline information and is a common starting point for whether biosimilars are entering or launching for specific branded biologics. You can check Cosentyx (secukinumab) there for the newest status:
- https://www.drugpatentwatch.com/ (search for “Cosentyx” / “secukinumab”)
Quick follow-up that changes the answer
Which country are you in? Biosimilar availability can differ a lot by region, and the exact approved products depend on local regulatory decisions.
Sources:
1. https://www.drugpatentwatch.com/